Cargando…

Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes

OBJECTIVES: This study aimed to assess the comparative efficacy of four ablation strategies on the incidence rates of freedom from atrial fibrillation (AF) or atrial tachycardia (AT) through a 3‐year follow‐up in patients with persistent AF. BACKGROUND: The optimal substrate modification strategies...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Yu‐Cheng, Lin, Yenn‐Jiang, Lo, Men‐Tzung, Chen, Yun‐Yu, Lin, Chin‐Yu, Lin, Chen, Chung, Fa‐Po, Lo, Li‐Wei, Chang, Shih‐Lin, Chao, Tze‐Fan, Hu, Yu‐Feng, Tuan, Ta‐Chuan, Liao, Jo‐Nan, Wu, Cheng‐I, Liu, Chih‐Min, Vicera, Jennifer‐Jeanne B., Chen, Chun‐Chao, Chin, Chye‐Gen, Lugtu, Isaiah C., Chen, Shih‐Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252615/
https://www.ncbi.nlm.nih.gov/pubmed/33825268
http://dx.doi.org/10.1111/jce.15033
_version_ 1783717339158544384
author Hsieh, Yu‐Cheng
Lin, Yenn‐Jiang
Lo, Men‐Tzung
Chen, Yun‐Yu
Lin, Chin‐Yu
Lin, Chen
Chung, Fa‐Po
Lo, Li‐Wei
Chang, Shih‐Lin
Chao, Tze‐Fan
Hu, Yu‐Feng
Tuan, Ta‐Chuan
Liao, Jo‐Nan
Wu, Cheng‐I
Liu, Chih‐Min
Vicera, Jennifer‐Jeanne B.
Chen, Chun‐Chao
Chin, Chye‐Gen
Lugtu, Isaiah C.
Chen, Shih‐Ann
author_facet Hsieh, Yu‐Cheng
Lin, Yenn‐Jiang
Lo, Men‐Tzung
Chen, Yun‐Yu
Lin, Chin‐Yu
Lin, Chen
Chung, Fa‐Po
Lo, Li‐Wei
Chang, Shih‐Lin
Chao, Tze‐Fan
Hu, Yu‐Feng
Tuan, Ta‐Chuan
Liao, Jo‐Nan
Wu, Cheng‐I
Liu, Chih‐Min
Vicera, Jennifer‐Jeanne B.
Chen, Chun‐Chao
Chin, Chye‐Gen
Lugtu, Isaiah C.
Chen, Shih‐Ann
author_sort Hsieh, Yu‐Cheng
collection PubMed
description OBJECTIVES: This study aimed to assess the comparative efficacy of four ablation strategies on the incidence rates of freedom from atrial fibrillation (AF) or atrial tachycardia (AT) through a 3‐year follow‐up in patients with persistent AF. BACKGROUND: The optimal substrate modification strategies using catheter ablation for patients with persistent AF remain unclear. METHODS: Patients with persistent AF were enrolled consecutively to undergo each of four ablation strategies: (a) Group 1 (Gp 1, n = 69), pulmonary vein isolation (PVI) plus rotor ablation assisted by similarity index and phase mapping; (b) Gp 2 (n = 75), PVI plus linear ablations at the left atrium; (c) Gp 3 (n = 42), PVI plus the elimination of complex fractionated atrial electrograms; (d) Gp 4 (n = 67), PVI only. Potential confounders were adjusted via a multivariate survival parametric model. RESULTS: Baseline characteristics were similar across the four groups. At a follow‐up period of 34.9 ± 38.6 months, patients in Gp 1 showed the highest rate of freedom from AF compared with the other three groups (p = .002), while patients in Gp 3 and 4 showed lower rates of freedom from AT than those of the other two groups (p = .006). Independent predictors of recurrence of AF were the ablation strategy (p = .002) and left atrial diameter (LAD) (p = .01). CONCLUSION: In patients with persistent AF, a substrate modification strategy using rotor ablation assisted by similarity index and phase mapping provided a benefit for maintaining sinus rhythm compared with the other strategies. Both ablation strategy and baseline LAD predicted the 3‐year outcomes of freedom from AT/AF
format Online
Article
Text
id pubmed-8252615
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82526152021-07-09 Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes Hsieh, Yu‐Cheng Lin, Yenn‐Jiang Lo, Men‐Tzung Chen, Yun‐Yu Lin, Chin‐Yu Lin, Chen Chung, Fa‐Po Lo, Li‐Wei Chang, Shih‐Lin Chao, Tze‐Fan Hu, Yu‐Feng Tuan, Ta‐Chuan Liao, Jo‐Nan Wu, Cheng‐I Liu, Chih‐Min Vicera, Jennifer‐Jeanne B. Chen, Chun‐Chao Chin, Chye‐Gen Lugtu, Isaiah C. Chen, Shih‐Ann J Cardiovasc Electrophysiol Original Articles OBJECTIVES: This study aimed to assess the comparative efficacy of four ablation strategies on the incidence rates of freedom from atrial fibrillation (AF) or atrial tachycardia (AT) through a 3‐year follow‐up in patients with persistent AF. BACKGROUND: The optimal substrate modification strategies using catheter ablation for patients with persistent AF remain unclear. METHODS: Patients with persistent AF were enrolled consecutively to undergo each of four ablation strategies: (a) Group 1 (Gp 1, n = 69), pulmonary vein isolation (PVI) plus rotor ablation assisted by similarity index and phase mapping; (b) Gp 2 (n = 75), PVI plus linear ablations at the left atrium; (c) Gp 3 (n = 42), PVI plus the elimination of complex fractionated atrial electrograms; (d) Gp 4 (n = 67), PVI only. Potential confounders were adjusted via a multivariate survival parametric model. RESULTS: Baseline characteristics were similar across the four groups. At a follow‐up period of 34.9 ± 38.6 months, patients in Gp 1 showed the highest rate of freedom from AF compared with the other three groups (p = .002), while patients in Gp 3 and 4 showed lower rates of freedom from AT than those of the other two groups (p = .006). Independent predictors of recurrence of AF were the ablation strategy (p = .002) and left atrial diameter (LAD) (p = .01). CONCLUSION: In patients with persistent AF, a substrate modification strategy using rotor ablation assisted by similarity index and phase mapping provided a benefit for maintaining sinus rhythm compared with the other strategies. Both ablation strategy and baseline LAD predicted the 3‐year outcomes of freedom from AT/AF John Wiley and Sons Inc. 2021-05-05 2021-06 /pmc/articles/PMC8252615/ /pubmed/33825268 http://dx.doi.org/10.1111/jce.15033 Text en © 2021 The Authors. Journal of Cardiovascular Electrophysiology Published by Wiley Periodicals LLC https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Hsieh, Yu‐Cheng
Lin, Yenn‐Jiang
Lo, Men‐Tzung
Chen, Yun‐Yu
Lin, Chin‐Yu
Lin, Chen
Chung, Fa‐Po
Lo, Li‐Wei
Chang, Shih‐Lin
Chao, Tze‐Fan
Hu, Yu‐Feng
Tuan, Ta‐Chuan
Liao, Jo‐Nan
Wu, Cheng‐I
Liu, Chih‐Min
Vicera, Jennifer‐Jeanne B.
Chen, Chun‐Chao
Chin, Chye‐Gen
Lugtu, Isaiah C.
Chen, Shih‐Ann
Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes
title Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes
title_full Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes
title_fullStr Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes
title_full_unstemmed Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes
title_short Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes
title_sort optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252615/
https://www.ncbi.nlm.nih.gov/pubmed/33825268
http://dx.doi.org/10.1111/jce.15033
work_keys_str_mv AT hsiehyucheng optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT linyennjiang optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT lomentzung optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT chenyunyu optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT linchinyu optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT linchen optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT chungfapo optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT loliwei optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT changshihlin optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT chaotzefan optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT huyufeng optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT tuantachuan optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT liaojonan optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT wuchengi optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT liuchihmin optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT vicerajenniferjeanneb optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT chenchunchao optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT chinchyegen optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT lugtuisaiahc optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes
AT chenshihann optimalsubstratemodificationstrategiesusingcatheterablationinpatientswithpersistentatrialfibrillation3yearfollowupoutcomes